Introduction {#sec1-1}
============

India has one of the highest burdens of tuberculosis (TB) globally, accounting for around 20% of all new TB cases annually.\[[@ref1]\] It is estimated that childhood TB constitutes 10--20% of all TB cases in high burden countries,\[[@ref2]\] accounting for 8--20% of TB-related deaths.\[[@ref3]\] Approximately, 25% of pediatric TB cases are extrapulmonary, with tuberculous meningitis (TBM) being the most severe form. Worldwide, TBM accounts for majority of the deaths due to TB.\[[@ref1]\] A study from South Africa (a high burden country) reported TB to be the commonest cause of childhood meningitis.\[[@ref4]\] TBM continues to be an important cause of morbidity (especially neurologic handicap) in children from resource-poor countries. Due to suboptimal performance of the diagnostic tests, TBM diagnosis requires vital clinical information coupled with supportive investigations (biochemical, immunological, and radiological).\[[@ref5]\] There have been few studies looking at the clinico-patho-radiological spectrum of this disease in children from India,\[[@ref6]\] with fewer addressing the outcome predictors.\[[@ref7][@ref8]\] This prospective, observational study was designed to address this issue.

Subjects and Methods {#sec1-2}
====================

Children of 3 months to 14 years of age with suspected TBM admitted to a tertiary care hospital from Western India were included in the study. TBM was suspected based on following features: Fever and/or a cough for ≥2 weeks, neurological symptoms (irritability, refusal to feed, headache, vomiting, altered sensorium, abnormal movements or seizure) with weight loss or poor weight gain. The diagnosis of TBM was based on the clinical case definition by Doerr *et al*. \[[Text box 1](#TB1){ref-type="table"}\].\[[@ref9]\] Ethical clearance was obtained from the Institute Ethics Committee and a written informed consent was taken from either of the parents/legal guardian before enrollment. TBM cases on treatment, those with underlying chronic illness or malignancy or HIV, and those on immunosuppressive therapy were excluded. Demographic data, immunization, contact with TB, and socioeconomic status were recorded.\[[@ref10]\] Detailed clinical examination, anthropometry, and the presence of Bacillus Calmette--Guérin (BCG) scar were recorded.\[[@ref11]\] The level of consciousness (modified Glassgow coma scale (GCS)), signs of raised intracranial pressure (ICP) and meningeal irritation was noted. Staging of tubercular meningitis was done as per British Medical Council Staging System \[[Text box 2](#TB2){ref-type="table"}\].\[[@ref12]\]

###### 

Clinical case definition of tuberculous meningitis devised by Doerr *et al*.
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###### 

British Medical Council Staging System for tubercular meningitis
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All the recruited children underwent chest X-ray, Mantoux test, and complete hemogram. Additional testing included gastric aspirate for acid-fast Bacilli (AFB), ultrasonography of abdomen and fine needle aspiration cytology from enlarged lymph nodes. A standard tuberculin skin test (5 TU) was used and results read after 72 h (positive: Induration of ≥10 mm; HIV and severe malnutrition: ≥5 mm was considered positive). Cerebrospinal fluid (CSF) analysis was done including the presence of AFB. All the children underwent neuroimaging (plain and contrast enhanced computed tomography or magnetic resonance imaging \[MRI\]). HIV testing was done where appropriate.

The data were entered into Microsoft excel sheet and analyzed using Stata 9.0 software (STATA Corp, College Station, TX, USA). Descriptive statistics was used along with analysis of risk factors by using Chi-square test or Fisher\'s test. A *P* \<0.05 was considered statistically significant.

Results {#sec1-3}
=======

Of 50 TBM cases, 47 met the eligibility criteria and were included. The baseline characteristics and clinical features are presented in [Table 1](#T1){ref-type="table"}. Majority of children were from lower socioeconomic status (85%) and were malnourished (76.6%). Fever, altered sensorium, and seizure were the most common symptoms. Contact history of TB was positive in 49% cases, 55% of children were BCG vaccinated, Mantoux test was positive in 25% \[[Table 1](#T1){ref-type="table"}\]. CSF examination could be done in 45 children (10% had opalescent appearance, no xanthochromia or hemorrhage or cobweb formation was noted). Chest X-ray abnormality was found in 38% \[[Table 2](#T2){ref-type="table"}\]. Common abnormalities noted on neuroimaging were: Communicating hydrocephalus (70%), meningeal enhancement (64%), and infarction (45%) \[[Table 2](#T2){ref-type="table"}\]. Meningeal enhancement was most commonly observed over the basal cisterns (47%) and cerebral cortex (43%). Infarction was most common in basal ganglion (67%) followed by cortex (41%).

###### 

Baseline and clinical characteristics of children with tubercular meningitis
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###### 

Laboratory and neuroimaging findings in children with tuberculous meningitis
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The mortality rate was 23.4% (11 of 47 died). Various risk factors associated with mortality or poor outcome were analyzed. Stage III disease, low GCS, and raised ICP were associated with increased mortality \[[Table 3](#T3){ref-type="table"}\], whereas biochemical and cytological parameters did not affect the outcome (data not shown). A significantly increased risk of mortality was found in children who were not vaccinated with BCG at birth.

###### 

Factors associated with mortality from tubercular meningitis in children
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Discussion {#sec1-4}
==========

We summarized the clinical, pathological, and radiological features of TBM and investigated characteristics associated with mortality. Children with TBM had nonspecific clinical pictures, boys were commonly affected, Mantoux positivity was in 25%, chest X-ray compatible with TB in 38% cases, and communicating hydrocephalus was the most common neuroimaging finding. Stage III disease, low GCS, and raised ICP were associated with increased mortality.

The male preponderance (1.5:1) observed in the present study was consistent with earlier pediatric studies from India.\[[@ref6][@ref7]\] Most common age group affected was \<3 years (60%) followed by 3--6 years (16%). Globally, children \<5 years of age have been found to be most vulnerable.\[[@ref13][@ref14][@ref15]\] Contact with TB could be elicited in about 50% of children in present study, this figure has been reported between 33% and 69% in various studies.\[[@ref6][@ref14][@ref15]\] This emphasizes the importance of eliciting contact history and family screening for TB in suspected cases of TBM. Despite being almost universally recommended and potentially highly effective, screening to provide preventive therapy for eligible contacts is still rarely implemented in TB endemic communities.\[[@ref16]\]

Though BCG vaccination is included under the universal immunization coverage, only 55% of children were vaccinated in the present study. As BCG vaccination protects against severe froms of TB (e.g., TBM, and disseminated or milliary TB), a lower vaccination coverage could explain a higher prevalence of severe from of TB (e.g., TBM) in the present study.\[[@ref17]\] Studies from India and Western countries have clearly documented the effect of BCG vaccine in reducing mortality from TBM.\[[@ref17][@ref18][@ref19]\] In a systematic review and metanalysis for treatment outcome of TBM in children, the authors emphasized on the role of BCG vaccination as an invaluable preventive measure for TBM.\[[@ref19]\] Our study demonstrated mantoux positivity only at mere 25% in children with TBM. TBM being an extra-pulmonary disease, a low rate of positive mantoux reaction in children with TBM is expected, though the rates vary widely.\[[@ref6][@ref7][@ref8][@ref14]\]

Most of the children (62%) in this study were detected at an advanced stage (Stage III). Advanced stage has been found to be the single most important factor associated with poor outcome,\[[@ref14]\] and the same has been echoed in our study. Mortality was nil in Stage I or Stage II disease but was 38% in Stage III disease. Cranial nerve palsy has been recognized as an important clinical indicator in differentiating TBM from pyogenic meningitis.\[[@ref20]\] In this study, 13% children present with cranial nerve palsy. Around 54% of children having GCS \<7 died, and GCS was found to be one of the predictors of mortality in the present study. This has been reported in previous Indian studies.\[[@ref8]\] Around 39% of children with raised ICP died, and this was found to be another predictors of mortality. Previous studies also report similar observation.\[[@ref8]\]

Abnormal chest X-ray was observed in 38% of patients in this study. A previous study found this figure as 44%.\[[@ref21]\] None of the radiological findings (chest X-ray, computed tomography scan, or MRI brain) predicted the mortality. While looking at the CSF findings, patients dying of TBM had higher mean CSF protein values and also CSF lymphocytic pleocytosis compared to those who survived.

The overall mortality in the present study was 23.4%. A previous systematic review reported this figure as 19.3%.\[[@ref22]\] However, in 10 years comparative retrospective analysis, one study reported this figure as 8% in children with TBM.\[[@ref23]\]

The strengths of the present study are prospective enrollment of children and careful documentation using a standardized predesigned data collection form. The case definition of TBM was also predefined, and the same was also used in a previous study from India, thus making it easier to compare the results. The limitations are: Being a single center study conducted at a tertiary care referral hospital, referral bias cannot be ruled out; TB culture and nucleic acid amplification tests (Genexpert) were not conducted on the CSF specimen; treatment outcome and follow-up of the patients to look for neurological sequelae could not be done.

The incidence of TBM indicates the annual risk of infection, and a robust surveillance system for documenting the occurrence of TBM in young children can improve estimates and monitoring of the TB burden and TB-related deaths in children.\[[@ref24]\] Newer and easier scoring systems need to be devised in the lights of ever increasing knowledge for better prediction of outcome of this dreaded disease.\[[@ref25]\] Furthermore, the survivors of tubercular meningitis are at a risk of long-term neurological sequelae ranging from residual paresis to subtle neurological deficit in the form of poor scholastic performance or even behavioral abnormalities. This mandates a close and regular follow-up of these children for early intervention.

Conclusion {#sec1-5}
==========

Tubercular meningitis continues to be associated with high rate mortality in children of countries with high burden of TB. Even with the advancement of scientific knowledge and technologies, including new techniques of laboratory and imaging diagnostic aid, very little prediction can be made regarding the prognosis of children with this dreaded disease. Our study highlighted few important predictors associated with mortality in this age group coupled with a reemphasis on need for early diagnosis, though the challenge remains to devise composite index systems in predicting outcome in TBM in future years.
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